135 related articles for article (PubMed ID: 6792691)
1. Enteric-coated aspirin in rheumatoid arthritis.
Bird HA; Rhind V; Leatham P; Saunders A; Wright V
Rheumatol Rehabil; 1981 May; 20(2):116-21. PubMed ID: 6792691
[TBL] [Abstract][Full Text] [Related]
2. How reliable is ESR as a measure of disease activity in rheumatoid arthritis treated with hydroxychloroquine?
Dixon JS; Greenwood M; Bird HA
Clin Rheumatol; 1988 Jun; 7(2):262-6. PubMed ID: 2901304
[TBL] [Abstract][Full Text] [Related]
3. A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis.
Aylward M; Maddock J; Wheeldon R; Parker RJ
Rheumatol Rehabil; 1975 May; 14(2):101-14. PubMed ID: 238274
[TBL] [Abstract][Full Text] [Related]
4. Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine.
Haataja M; Nissilä M; Ruutsalo HM
Scand J Rheumatol; 1978; 7(4):212-4. PubMed ID: 104378
[TBL] [Abstract][Full Text] [Related]
5. [Enteric aspirin tablets and the salicylate concentration in the plasma in the morning].
Laine V; Strandman D; Tikkanen R
Lakartidningen; 1968 Sep; 65(39):3832-7 passim. PubMed ID: 5741894
[No Abstract] [Full Text] [Related]
6. Blood salicylate levels and clinical trials with a new form of enteric-coated aspirin: studies in rheumatoid arthritis and degenerative joint disease.
Baum J
J Clin Pharmacol J New Drugs; 1970; 10(2):132-7. PubMed ID: 4906542
[No Abstract] [Full Text] [Related]
7. A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis.
Jessop JD; O'Sullivan MM; Lewis PA; Williams LA; Camilleri JP; Plant MJ; Coles EC
Br J Rheumatol; 1998 Sep; 37(9):992-1002. PubMed ID: 9783766
[TBL] [Abstract][Full Text] [Related]
8. A trial of micro-encapsulated and enteric-coated aspirin in rheumatoid arthritis.
Dippy JE; Pritchard MH; Lloyd KN
Rheumatol Rehabil; 1976 May; 15(2):77-80. PubMed ID: 778989
[TBL] [Abstract][Full Text] [Related]
9. The effects of enteric coating of aspirin tablets on occult gastrointestinal blood loss.
Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG
Aust N Z J Med; 1977 Dec; 7(6):600-4. PubMed ID: 350214
[TBL] [Abstract][Full Text] [Related]
10. Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.
Armstrong BK; Ukich AW; Goatcher PM
Med J Aust; 1970 Jul; 2(4):181-3. PubMed ID: 4917130
[No Abstract] [Full Text] [Related]
11. Rheumatoid arthritis V: therapy with remission-inducing agents.
Gaines LM
Md State Med J; 1982 Sep; 31(9):49-50. PubMed ID: 6815385
[No Abstract] [Full Text] [Related]
12. The bioavailability of enteric-coated acetylsalicylic acid: a comparison with buffered ASA in rheumatoid arthritis II.
Canada AT; Little AH; Creighton EL
Curr Ther Res Clin Exp; 1976 May; 19(5):554-7. PubMed ID: 820521
[No Abstract] [Full Text] [Related]
13. Biochemical indices of response to hydroxychloroquine and sodium aurothiomalate in rheumatoid arthritis.
Dixon JS; Pickup ME; Bird HA; Lee MR; Wright V; Downie WW
Ann Rheum Dis; 1981 Oct; 40(5):480-8. PubMed ID: 6796009
[TBL] [Abstract][Full Text] [Related]
14. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
Kovarsky J
Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276
[No Abstract] [Full Text] [Related]
15. Disease-modifying drugs for progressive rheumatoid arthritis.
Bunch TW; O'Duffy JD
Mayo Clin Proc; 1980 Mar; 55(3):161-79. PubMed ID: 6766523
[TBL] [Abstract][Full Text] [Related]
16. A clinical and biochemical evaluation of Clozic, a novel disease modifying drug in rheumatoid arthritis.
Bird HA; Dixon JS; Finney PL; Leatham PA; Lowe JR; Pickup ME; Rhind VM; Rushton A; Sitton NG; Wright V
Clin Exp Rheumatol; 1983; 1(2):93-9. PubMed ID: 6398158
[TBL] [Abstract][Full Text] [Related]
17. Aspirin dosing using 15 grain enteric coated tablets.
Pollet S; White RH; Jang H; Yim CW; Feigal D
J Rheumatol; 1985 Apr; 12(2):337-42. PubMed ID: 4032405
[TBL] [Abstract][Full Text] [Related]
18. Slow acting antirheumatic drugs in patients with juvenile rheumatoid arthritis--evaluated in a randomized, parallel 50-week clinical trial.
Kvien TK; Høyeraal HM; Sandstad B
J Rheumatol; 1985 Jun; 12(3):533-9. PubMed ID: 3930720
[TBL] [Abstract][Full Text] [Related]
19. Treatment of rheumatoid arthritis with flurbiprofen: a comparison with enteric-coated aspirin.
Dequeker J; Mardjuardi A
Curr Med Res Opin; 1981; 7(7):418-22. PubMed ID: 7021070
[TBL] [Abstract][Full Text] [Related]
20. Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs.
Grindulis KA; Scott DL; Robinson MW; Bacon PA; McConkey B
Br J Rheumatol; 1985 May; 24(2):158-63. PubMed ID: 2859902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
